Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Meraviglia

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Cellular & Molecular Immunology|July 25, 2017
Clonal expansion shapes the human Vδ1T cell receptor repertoireSerena Meraviglia, Francesco Dieli
Cellular & Molecular Immunology|October 1, 2020
Vitamin C as a promoter of γδ T cellsSerena Meraviglia, Francesco Dieli
Current Opinion in Investigational Drugs (London, England : 2000)|September 30, 2008
Advances in immunotherapy of castration-resistant prostate cancer: bisphosphonates, phosphoantigens and moreFrancesco Dieli, Nadia Caccamo, Serena Meraviglia
Frontiers in Immunology|December 16, 2014
Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor MicroenvironmentElena Lo Presti, Franceso Dieli, Serena Meraviglia
Vaccines|June 2, 2021
Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic OpportunitiesElena Lo Presti, Francesco Dieli, Serena Meraviglia
Immunotherapy|November 17, 2015
γδ T cell-based anticancer immunotherapy: progress and possibilitiesSerena Meraviglia, Elena Lo Presti, Francesco Dieli, et al.
Cellular & Molecular Immunology|March 20, 2026
Reprogramming the immune orchestra for glioblastoma: oncolytic viruses and the B-cell connectionCostanza Dieli, Marta Di Simone, Francesco Dieli, et al.
Medicina Nei Secoli|October 27, 2005
[The evolution of didactic programs of Italian medical faculties towards an European standard]Alfredo Salerno, Nadia Caccamo, Serena Meraviglia, et al.
Oncoimmunology|November 19, 2013
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cellsMatilde Todaro, Serena Meraviglia, Nadia Caccamo, et al.
Current Cancer Drug Targets|January 22, 2010
Gammadelta T cell modulation in anticancer treatmentNadia Caccamo, Francesco Dieli, Serena Meraviglia, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Cellular & Molecular Immunology|July 25, 2017
Clonal expansion shapes the human Vδ1T cell receptor repertoireSerena Meraviglia, Francesco Dieli
Cellular & Molecular Immunology|October 1, 2020
Vitamin C as a promoter of γδ T cellsSerena Meraviglia, Francesco Dieli
Current Opinion in Investigational Drugs (London, England : 2000)|September 30, 2008
Advances in immunotherapy of castration-resistant prostate cancer: bisphosphonates, phosphoantigens and moreFrancesco Dieli, Nadia Caccamo, Serena Meraviglia
Frontiers in Immunology|December 16, 2014
Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor MicroenvironmentElena Lo Presti, Franceso Dieli, Serena Meraviglia
Vaccines|June 2, 2021
Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic OpportunitiesElena Lo Presti, Francesco Dieli, Serena Meraviglia
Immunotherapy|November 17, 2015
γδ T cell-based anticancer immunotherapy: progress and possibilitiesSerena Meraviglia, Elena Lo Presti, Francesco Dieli, et al.
Cellular & Molecular Immunology|March 20, 2026
Reprogramming the immune orchestra for glioblastoma: oncolytic viruses and the B-cell connectionCostanza Dieli, Marta Di Simone, Francesco Dieli, et al.
Medicina Nei Secoli|October 27, 2005
[The evolution of didactic programs of Italian medical faculties towards an European standard]Alfredo Salerno, Nadia Caccamo, Serena Meraviglia, et al.
Oncoimmunology|November 19, 2013
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cellsMatilde Todaro, Serena Meraviglia, Nadia Caccamo, et al.
Current Cancer Drug Targets|January 22, 2010
Gammadelta T cell modulation in anticancer treatmentNadia Caccamo, Francesco Dieli, Serena Meraviglia, et al.
Pageof 9